Target intelligence / Profile preview

Cellular debris and apoptotic bodies (ApoBDs)

Target
ApoBDs
Molecular classification
Extracellular vesicles, Cellular components, Other
01

Overview

Cellular debris and apoptotic bodies are the heterogeneous remnants of cells that have undergone programmed or accidental cell death. Apoptotic bodies (ApoBDs) are a specific class of extracellular vesicles, typically 1–5 μm in diameter, that form during the late stages of apoptosis to sequester intracellular components and prevent the release of inflammatory contents (Poon et al., 2014, Nature Communications). These bodies are characterized by the externalization of phosphatidylserine, which acts as a critical "eat-me" signal for recognition by phagocytes (Elliott & Ravichandran, 2010, Nature). The efficient clearance of these remnants, a process known as efferocytosis, is vital for maintaining tissue homeostasis and preventing the onset of autoimmune responses. When clearance mechanisms fail, cellular debris can undergo secondary necrosis, releasing damage-associated molecular patterns (DAMPs) that trigger chronic inflammation and diseases such as systemic lupus erythematosus (Mahajan et al., 2016, Frontiers in Immunology). While cellular debris is not a discrete molecular drug target, the pathways and receptors involved in its engulfment, such as the TAM receptor family, are significant focal points for therapeutic intervention in oncology and autoimmune disorders.

Other names
Apoptotic bodiesApoBDsCellular fragmentsNecrotic debrisCellular remnantsApoptotic vesicles
02

Mechanism of action

Not applicable as this is a heterogeneous collection of cellular remnants rather than a specific molecular target.

03

Biological functions

ApoptosisEfferocytosisImmune modulationAntigen presentationTissue homeostasisOther
04

Disease associations

Systemic lupus erythematosusRheumatoid arthritisAtherosclerosisCancerChronic inflammationOther
05

Safety considerations

Risk of systemic autoimmunity if clearance is impairedPro-inflammatory potential of necrotic debrisInduction of cytokine storms in severe tissue injury
06

Biomarkers

Phosphatidylserine exposureCirculating cell-free DNA (cfDNA)Annexin V bindingCalreticulin exposure

Beyond the preview

Go deeper on Cellular debris and apoptotic bodies (ApoBDs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular debris and apoptotic bodies (ApoBDs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call